Autopsy report · NCT04060563

Frequency Specific Microcurrent for the Treatment of Diastasis Recti

“Enrollment too slow.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 6 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 2 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Diana Trang

Sponsor type

US federal agency

Conditions

Diastasis Recti

Interventions

INSPIRSTAR IS02 MICROCURRENT STIMULATOR

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (93% match in meaning)
• A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC
  “Slow enrollment.” (91% match in meaning)
• A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
  “Enrollment was too slow” (91% match in meaning)
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
  “due to slow enrollment” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.